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1. Introduction 
The glycerol phosphate pathway of fatty acid 
esterification is one of the biosynthetic routes to 
glycerolipids. Glycerol phosphate acyltransferase 
(GPAT), is a possible site of control of this process, 
being the first committed enzyme. Little is known 
about regulation of glycerolipid synthesis although 
recent studies in adipose tissue indicate the possibility 
of acute hormonal regulation of GPAT activity [1,2]. 
In order to establish abasis for studies of short-term 
insulin action on hepatic GPAT in the intact animal 
the effect of mild diabetes on the mitochondrial nd 
microsomal enzymes has been investigated. Effects 
of insulin on GPAT in the perfused rat liver are 
presented [3]. A statistically inconclusive study of 
the effect of starvation on hepatic GPAT has been 
made [4], but there do not appear to be any previous 
reports of the effect of diabetes. The present results 
show an interesting divergence in the responses of the 
mitochondrial nd microsomal ctivities. 
2. Materials and methods 
Male Sprague Dawley rats (120-130 g)were sub- 
cutaneously injected with streptozotocin (100 mg/kg) 
dissolved in 50 mM citrate, 0.15 M NaC1 buffer, 
pH 4.0. Every 24 h for six days each animal received 
a subcutaneous injection of 1.6 IU protamine zinc 
insulin. Insulin was then withdrawn and animals 
showing a strongly positive 'Clinistix' test for urine 
glucose were taken to be diabetic and killed on the 
fourth day thereafter. Control animals received only a 
single injection of citrate-NaCl buffer at 120-130 g 
body wt. Growth curves of diabetic rats during insulin 
maintenance were comparable with controls. All 
animals had constant access to food and water. 
Rats were killed by a blow on the head and blood 
collected from the mouth into a heparinised syringe. 
Analysis of glucose [5] and non-esterified fatty acids 
[6] were performed on samples of plasma. The entire 
liver was homogenised in 80 ml ice-cold 0.25 M 
sucrose, 10 mM Tris-chloride, 1mM EDTA, pH 7.4 
and centrifuged at 620 X g for 10 min. The super- 
natant was then centrifuged at 7250 × g for 10 min 
and the resulting mitochondrial pellet washed twice 
with 30 ml homogenising buffer by resuspension a d 
centrifugation at9200 × g for 10 min. The washed 
mitochondria were then resuspended in 0.25 M 
sucrose, 10 mM Tris-chloride, 1mM EDTA dithio- 
threitol, pH 7.4, at 5 -6  mg protein/ml. Microsomes 
were obtained by centrifuging the 7250 X g post- 
mitochondrial supernatant a 105 000 X g 1 h and 
the pellet resuspended in 0.25 M sucrose, 10 mM 
Tris-chloride, 1mM EDTA, 1 mM dithiothreitol, 
pH 7.4, at 3-5 mg protein/ml. 
Glutamate dehydrogenase (EC 1.4.1.2) was 
assayed at 25°C by the method [7] after treatment 
of samples with 0.1% (v/v) Triton X.100. NADP- 
cytochrome c reductase (EC 1.6.2.4) was assayed at 
25°C by the method [8]. Glucose 6-phosphatase 
(EC 3.1.3.9) was assayed at 37°C in final vol. 3.9 ml 
containing 90 mM sodium acetate buffer, pH 6.3, 
5.1 mM glucose 6-phosphate and the phosphate 
released measured by the method [9]. These enzyme 
activities were all measured in whole homogenates, 
mitochondria and microsomes. 
Acyl CoA, L-glycerol 3-phosphate-o-acyltransferase 
(EC 2.3.1.15) was assayed at 30°C in final vol. 1.0 ml 
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containing 120 mM KC1, 50 mM Tris-chloride buffer, 
pH 7.4, 0.6/aCi L-[U)4C]glycerol 3-phosphate, 
65/aM palmitoyl CoA, 0.7 mM dithiothreitol and the 
indicated L-glycerol 3-phosphate concentration. I  
addition, 1.75 mg or 6 mg of fatty acid-poor albumin 
were added to microsomal and mitochondrial ssays, 
respectively. The reaction was initiated with 0.1 ml 
microsomes or mitochondria and performed for 3 
rain during which incorporation of carbon-14 was 
linear with time. The reaction was terminated with 
2 ml water-saturated butanol and radioactive 
incorporation i to butanol-soluble products deter- 
mined as described [10]. One unit of enzyme activity 
represents he conversion of 1/amol substrate to 
products/min atthe specified temperature. 
Protein in whole homogenates, mitochondria or
microsomes was determined by a biuret method [11] 
modified by the addition of 1% (w/v) deoxycholate. 
DNA in fresh homogenates was measured by the 
method [12]. 
Statistical analysis of data was performed using the 
Student's t test modified by Bessel's correction factor 
for small samole~ 
3. Results and d iscuss ion  
Table 1 shows general characteristics of the diabetic 
animals and their controls. In addition, details of the 
three marker enzymes used as reference activities are 
tabulated. Plasma from diabetic animals had consider- 
ably elevated glucose levels but no significant increases 
in non-esterified fatty acid suggesting that the rats 
were unlikely to be ketotic. 
Recent studies in adipose tissue [13] have suggested 
that long chain fatty acyl CoA synthetase may be 
regulated by insulin. Therefore it was considered 
inadvisable to employ a fatty acyl CoA generating 
system dependent on endogenous fatty acyl CoA 
synthetase for the assay of GPAT. Accordingly pal- 
mitoyl CoA was used as the acyl substrate. A saturated 
rather than unsaturated acyl entity was chosen to 
Table 1 
General characteristics of control and diabetic animals 
Control 
(5 animals) 
Body weight (g) 
Liver weight (g) 
Total liver DNA (mg) 
Total liver protein (g) 
Plasma glucose (rag/100 ml) 
Plasma non-esterified fatty acid (raM) 
Glutamate dehydrogenase activity: 
Diabetic P 
(7 animals) 
194 -+ 4 
7.9 +- 0.3 
32.6 +- 1.3 
1.60 +- 0.05 
113.2 -+ 8.8 
0.70 -+ 0.11 
156 -+ 3 
6.2 -+ 0.2 
34.4 ± 1.3 
1.56 -+ 0.03 
369.2 -+ 24.2 
0.88 -+ 0.08 
<0.001 
<0.001 
n.s .  
n . s .  
<0.001 
n.s .  
units/liver 
units/mg DNA 
units/mg mitochondrial protein 
NADP cytochrome c reductase activity: 
units/liver 
units/mg DNA 
units/mg microsomal protein 
Glucose 6-phosphatase activity: 
units/liver 
units/mg DNA 
units/mg microsomal protein 
1509 +- 78 
46.3 -+ 2.0 
2.55 -+ 0.10 
75.9 -+ 11.2 
2.31 -+ 0.28 
0.13 -+ 0.01 
87.9 -+ 4.4 
2.71 -+ 0.17 
0.15 -+ 0.02 
1571 -* 76 
46.1 +- 1.6 
2.68 -* 0.15 
77.3 + 3.3 
2.28 ~: 0.13 
0.19 -* 0.01 
195.2 -+ 14.2 
5.71 ± 0.33 
0.53 -+ 0.03 
n.s .  
n . s .  
n.s. 
n.s .  
n . s .  
<0.01 
<0.001 
<0.001 
<0.001 
All values are expressed asmeans -+ SEM 
n.s. indicates P > 0.05 
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Fig.1. Specific activities of mitochondrial and microsomal GPAT/mg protein. (la.) Mitochondrial ctivities: (o) control; (e) 
diabetic. (lb3 Microsomal ctivities: (a) control; (m) diabetic. 
ensure high acylation rates in both mitochondria 
and microsomes [14,15]. To obtain optimum assay 
conditions for GPAT it was necessary to use different 
albumin concentrations i  mitochondria and 
microsomes. 
Fig.la shows that mitochondfial GPAT specific 100 
activity expressed per mg protein was decreased in
diabetic animals. This decrease was significant at all ,-4 
glycerol phosphate concentrations (P < 0.001,0.01, < z 80! 
D 0.02, 0.01,0.05, 0.02 for 0.5, 1,2, 3, 4 and 5 mM 
glycerol phosphate respectively) and varied between E 
20 and 29%, the mean being 24%. However, micro- "~ 6E 
somal GPAT specific activity per mg protein was .~ 
increased by 44 - 73% in diabetic animals 
(P < 0.01 in all cases except P < 0.02 at 5 mM ~ L0 
glycerol phosphate) the mean increase being 58% 
(fig.lb). Since total liver protein was not changed in 
diabetic rats (table 1) we presume that this could ~ 2C 
reflect a selective decrease in microsomal fraction 
i - . -  
protein. 
From the whole homogenate contents of marker (.9 0 r 
enzymes and DNA, together with the GPAT and t 
marker enzyme content of subcellular f actions, 
mitochondrial nd microsomal GPAT activity per total 
mg liver DNA can also be calculated. This treatment 
corrects for incomplete recoveries of mitochondria 
and microsomes and we consider it more reliable than 
expression of activity per protein. Fig.2 shows that 
mitochondrial GPAT activity also decreased per mg 
) '  i '  ~ ' 5 '  ~ ' ~ 
GLYCEROL PHOSPHATE CONCN.(n'N). 
Fig.2. Activity of mitochondrial GPAT expressed/mg total 
liver DNA. Mitochondrial ctivities were calculated using 
glutamate d hydrogenase  marker: (o) control; (o) diabetic. 
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DNA in diabetics (P < 0.01,0 .01,0 .05,0 .01,0 .05,  
0.05 for 0.5, 1,2, 3, 4 and 5 mM glycerol phosphate 
respectively). This decrease varied between 23 and 
33%, the mean being 28%. Since total liver DNA and 
glutamate dehydrogenase w re unchanged in diabetes 
(table 1), a real decrease in the total mitochondrial 
GPAT activity per liver had occurred. On the other 
hand microsomal GPAT activity per mg DNA was 
essentially unchanged by diabetes. Using NADP- 
cytochrome c reductase as marker a small but non- 
significant increase in GPAT activity was apparent in 
diabetic livers, whereas with glucose 6 phosphatase 
as marker diabetes apparently caused a small but 
non-significant decrease in microsomal GPAT. 
Contamination of mitochorrdrial GPAT with an 
invariant microsomal GPAT activity could lead to 
some underestimation f  the percentage decrease 
in the mitochondrial ctivity due to diabetes. This 
is in fact small for two reasons. Firstly, the percentage 
of glucose 6 phosphatase in the mitochondrial 
fraction was only 10.5 -+ 1.6% and 6.8 + 0.5% in 
controls and diabetics respectively. Corresponding 
contamination of microsomes by glutamate dehydro- 
genase was 20.9 -+ 2.0% and 14.6 + 2.8% in controls 
and diabetic livers. Secondly, cross contaminating 
GPAT activities are measured under quite suboptimal 
conditions due to the use of  different albumin con- 
centrations in the mitochondrial nd microsomal 
assays. 
These results uggest a selective response of the 
mitochondrial GPAT to mild diabetes. It is noteworthy 
that the very different responses seen with thiol 
reagents [3,15,16] could suggest hat the 
mitochondri',,t and microsomal GPAT activities reside 
in different enzymes. Whether the decrease in 
mitochondrial GPAT reflects an acute regulatory 
response or some gross change in amount of enzyme 
protein is unclear at present. The effect of insulin on 
GPAT activity in perfused rat liver seen in the accom- 
panying paper [3] however suggests that acute regula- 
tion by insulin may occur. A mitochondrial GPAT 
activity varying in response to insulin is obviously of 
relevance to interrelated control of fatty acid esterifi- 
cation and oxidation. 
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